Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal dysplasia and evidence for locus heterogeneity. Issue 8 (7th April 2016)

• Record Type: Journal Article
• Authors: Iida, Aritoshi; Xing, Weirong; Docx, Martine K F; Nakashima, Tomoki; Wang, Zheng; Kimizuka, Mamori; Van Hul, Wim; Rating, Dietz; Spranger, Jürgen; Ohashi, Hirohumi; Miyake, Noriko; Matsumoto, Naomichi; Mohan, Subburaman; Nishimura, Gen; Mortier, Geert; Ikegawa, Shiro
• Is Part Of: Journal of medical genetics. Volume 53:Issue 8(2016)
• Page Start: 568
• Page End: 574
• Publication Date: 2016-04-07
• Subjects: Osteosclerotic metaphyseal dysplasia -- Whole exome sequencing -- LRRK1 mutation -- Lrrk1 deficient mouse; Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmedgenet-2016-103756
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Background: Osteosclerotic metaphyseal dysplasia (OSMD) is a unique form of osteopetrosis characterised by severe osteosclerosis localised to the bone ends. The mode of inheritance is autosomal recessive. Its genetic basis is not known. Objective: To identify the disease gene for OSMD. Methods and results: By whole exome sequencing in a boy with OSMD, we identified a homozygous 7 bp deletion (c.5938_5944delGAGTGGT) in the LRRK1 gene. His skeletal phenotype recapitulated that seen in the Lrrk1 -deficient mouse. The shared skeletal hallmarks included severe sclerosis in the undermodelled metaphyses and epiphyseal margins of the tubular bones, costal ends, vertebral endplates and margins of the flat bones. The deletion is predicted to result in an elongated LRRK1 protein (p.E1980Afs*66) that lacks a part of its WD40 domains. In vitro functional studies using osteoclasts from Lrrk1 -deficient mice showed that the deletion was a loss of function mutation. Genetic analysis of LRRK1 in two unrelated patients with OSMD suggested that OSMD is a genetically heterogeneous condition. Conclusions: This is the first study to identify the causative gene of OSMD. Our study provides evidence that LRRK1 plays a critical role in the regulation of bone mass in humans.